Given that ZNF300 is up-regulated in cancer, and promotes inflammation and metastasis, the repression of ZNF300P1 associated with methylation in ovarian cancer make it unlikely to be functioning as an miRNA decoy. This evidence concerns the gene ZNF300 and ovarian cancer.